Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.79 - $30.86 $983,787 - $1.71 Million
55,300 Added 120.48%
101,200 $1.87 Million
Q4 2023

Feb 14, 2024

BUY
$20.78 - $31.77 $480,018 - $733,887
23,100 Added 101.32%
45,900 $1.44 Million
Q3 2023

Nov 14, 2023

BUY
$20.84 - $33.47 $475,152 - $763,116
22,800 New
22,800 $475,000
Q1 2023

May 15, 2023

BUY
$16.32 - $20.92 $1.17 Million - $1.5 Million
71,600 New
71,600 $1.35 Million
Q3 2022

Nov 14, 2022

BUY
$14.11 - $18.27 $251,158 - $325,206
17,800 New
17,800 $291,000
Q2 2022

Aug 15, 2022

SELL
$13.01 - $27.22 $18,214 - $38,108
-1,400 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$20.94 - $27.5 $29,316 - $38,500
1,400 New
1,400 $34,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.